difluprednate: Clinical Trials

12 trials of difluprednate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated. 8 Phase 3, 3 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 43Terminated 2, Completed 1
Phase 21Completed 1

Follow difluprednate: new trials by email Literature Review of difluprednate trials Research Report on difluprednate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery
Dextenza 0.4mg intracanalicular Insert, Durezol 0.05% Ophthalmic Emulsion - Cataract
Phase 4TerminatedCathleen McCabe MD12020-12-012022-11-10
Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification
Difluprednate 0.05%, Prednefrin - Cataract
Phase 3CompletedLaboratorios Sophia S.A de C.V.1782018-10-042019-12-02
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
Difluprednate, Nepafenac, Prednisolone acetate - Uveitis, Macular Edema
Phase 4TerminatedUniversity of California, San Francisco92018-09-122021-01-13
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
Difluprednate 0.05% ophthalmic emulsion, Difluprednate vehicle - Dry Eye Disease
Phase 2CompletedAlcon Research7222011-02-012013-03-11
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
Difluprednate 0.05% ophthalmic emulsion, Prednisolone acetate 1.0% ophthalmic suspension - Endogenous Anterior Uveitis
Phase 3CompletedAlcon Research1112010-10-012012-11-15
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
Difluprednate ophthalmic emulsion, 0.05%, Prednisolone acetate ophthalmic suspension, 1.0% - Cataracts, Inflammation
Phase 3CompletedAlcon Research802010-08-012013-06-19
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
Difluprednate ophthalmic emulsion 0.05%, Prednisolone acetate 1% - Cataracts, Corneal Edema
Phase 4CompletedEdward J. Holland522009-03-012012-08-08
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
Difluprednate, Placebo - Inflammation
Phase 3CompletedSirion Therapeutics, Inc.1202008-01-012011-07-01
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
Difluprednate, Placebo - Inflammation
Phase 3CompletedSirion Therapeutics, Inc.1202007-12-012011-06-30
Study of Difluprednate in the Treatment of Uveitis
Difluprednate, Prednisolone Acetate - Uveitis
Phase 3CompletedSirion Therapeutics, Inc.2008-08-29
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
Difluprednate, Placebo - Inflammation
Phase 3CompletedSirion Therapeutics, Inc.2192009-07-02
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)
Difluprednate, Placebo - Inflammation
Phase 3CompletedSirion Therapeutics, Inc.2192009-07-02

Conditions studied

Inflammation (5)  ·  Cataract (4)  ·  Uveitis (2)  ·  Corneal Edema (1)  ·  Dry Eye Syndromes (1)  ·  Macular Edema (1)

Sponsors

Sirion Therapeutics, Inc. (5)  ·  Alcon Research (3)  ·  Cathleen McCabe MD (1)  ·  Edward J. Holland (1)  ·  Laboratorios Sophia S.A de C.V. (1)  ·  University of California, San Francisco (1)

Countries

United States (10)  ·  India (1)  ·  Mexico (1)

Top investigators

Roger Vogel, MD (5)  ·  Cathleen M McCabe, MD (1)  ·  Edward J Holland, MD (1)  ·  Eric D Donnenfeld, MD (1)  ·  Kerry S Solomon, MD (1)  ·  Nisha Acharya, MD MS (1)

Results publications

PMID 19101421, PMID 20809807, PMID 21704965, PMID 24677110, PMID 32606573